Reinfection with SARS-CoV-2 in a patient undergoing chemotherapy for lymphoma: Case report.
Florence CôtéJulie Bestman-SmithMarie GourdeauShawn M SimpsonMarie-Ève HamelinJulie CarbonneauAntoine ChiassonMarieke RozendaalMartin A SmithGuy BoivinPublished in: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada (2022)
This case report highlights that reinfection can occur rapidly (62-67 d) among immunocompromised patients after a prolonged disease. We provide substantial proof of prolonged infection through repeated nucleic acid amplification tests and positive viral culture at day 56 of the disease course, and we put forward evidence of reinfection with viral genome sequencing.
Keyphrases
- case report
- sars cov
- nucleic acid
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- respiratory syndrome coronavirus
- prognostic factors
- diffuse large b cell lymphoma
- peritoneal dialysis
- squamous cell carcinoma
- single cell
- gene expression
- genome wide
- radiation therapy
- locally advanced
- dna methylation
- acute respiratory distress syndrome